Tune Therapeutics
Dan McHugh is a Board Member at Tune Therapeutics and a Senior Director at Emerson Collective.
Dan is a Senior Director at Emerson Collective where he has been leading the organization’s life sciences investment efforts since 2016. At Emerson, he supports companies developing novel therapeutics, diagnostics, and other enabling technologies with the potential for impact in oncology.
Prior to Emerson Collective, Dan was a strategy consultant at Bain & Co., working primarily with biopharmaceutical and private equity clients.
He holds a B.S. in Bioengineering and an M.S. in Management Science & Engineering, both from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Tune Therapeutics
1 followers
With its versatile and powerful TEMPO epigenomic control platform, Tune Therapeutics is pioneering a new therapeutic modality that can fine-tune any gene network and unlock the full power and potential of regenerative medicine. With deep experience and a passionate commitment to exploration and innovation, Tune is driving through an inflection point in the history of genetic medicine: from targeting a limited range of rare conditions, to addressing thousands of common and complex diseases for which no curative treatment is available.